Positive Phase 2 Trial Results Released for Idiopathic Pulmonary Fibrosis Treatment
Data from a Phase 2 trial examining BI 10115550, an oral treatment for idiopathic pulmonary fibrosis (IPF), has just been released. This data shows that this therapy is able to…